ELILDirexion Daily LLY Bull 2X Shares
Seeks daily investment results of 200% of the daily performance of LLY.
By Direxion Funds · Launched 2025
Annual Cost
1.07%
#5,550 of 6,040 · expensive
Fund Size
$17M
#4,644 of 6,040 · small
Return (1Y)
+84.7%
Track Record
1 year
#4,197 of 6,040 · young
Performance
Total-return NAV · USDGrowth of $10,000
$18,637+86.4%
Total-return NAV, USD. Net of fund fees, before tax.
What's inside
How Beacon categorizes this fundAsset class
EquityStrategy
Leveraged
Holdings
By weightConcentration
single-stock exposure — holdings shown are derivatives collateral, not the fund's position
GOLDMAN SACHS LIQ ES FD A
27.9%
DREYFUS
17.9%
DREYFUS GOVERNMENT CASH MANAGE
15.7%
ELI LILLY & COMPANY
15.3%
GOLDMAN FINANCIAL
11.0%
N/A
0.9%
N/A
-1.0%
N/A
-1.5%
N/A
-2.5%
Asset allocation
Other
63.7%
Cash
30.0%
Stocks
6.3%
By sector
Healthcare
100.0%
Risk profile
Last 12 months · Sharpe & Sortino need 3+ yearsVolatility (1Y)
70.9%High
Year-on-year price swings
Max drawdown
-56.0%Severe
Worst peak-to-trough loss
Sharpe (3Y)
Unavailable
Needs 3+ years of history
Sortino (3Y)
Not yet
Needs 3+ years of history
Listing
- Exchange
- NASDAQ Global Select Market
Full fund details
- Objective
- Seeks daily investment results of 200% of the daily performance of LLY.
- Strategy
- Invests at least 80% of net assets in securities of LLY and financial instruments, such as swap agreements, to provide 2X daily leveraged exposure to LLY. Concentrated in the healthcare sector and pharmaceutical industry, with daily rebalancing to maintain exposure.
- Inception date
- March 25, 2025
- Fund family
- Direxion Funds
Similar funds
Same asset class, closest by strategy & exposureNext steps
Save ELIL to compare it with other funds, or start building a portfolio.
Data updated on 2026-09-18